World's Most Expensive Medicine: Is it Worth It?

Is it worth $1 million to treat a potentially fatal genetic disease that causes painful swelling of the pancreas and can require repeated trips to the emergency room? Germany says it’s not sure.

Health authorities there ruled Thursday that the benefit of Glybera, the first gene therapy approved for use in Europe, is “not quantifiable” and more data on safety and efficacy are needed to start a new assessment in June 2016.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news